Literature DB >> 34079187

A Case of Paraneoplastic Pemphigus as a Preceding Manifestation of Underlying Follicular Lymphoma Treated with R-CHOP.

Minsu Kim1, Ji Yun Lee2, Soo-Chan Kim3, Jung-Im Na1.   

Abstract

Paraneoplastic pemphigus is a rare, life-threatening disorder associated with an underlying neoplasm, which presents with painful stomatitis and polymorphous skin lesions. Successful diagnosis of paraneoplastic pemphigus can lead to the diagnosis and treatment of the underlying malignancy. However, involvement of the respiratory system is typically unresponsive to treatment. Herein, we report the case of a 44-year-old female diagnosed with paraneoplastic pemphigus with underlying follicular lymphoma treated with a chemotherapy regimen including rituximab. Her skin lesions and underlying lymphoma responded to treatment, but bronchiolitis obliterans continued to progress and resulted in fatal respiratory failure.
Copyright © 2021 The Korean Dermatological Association and The Korean Society for Investigative Dermatology.

Entities:  

Keywords:  Bronchiolitis obliterans; Follicular lymphoma; Paraneoplastic pemphigus; Rituximab

Year:  2021        PMID: 34079187      PMCID: PMC8137331          DOI: 10.5021/ad.2021.33.3.271

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  9 in total

Review 1.  Paraneoplastic pemphigus.

Authors:  Grant J Anhalt
Journal:  J Investig Dermatol Symp Proc       Date:  2004-01

2.  Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab.

Authors:  Jun Aoi; Katsunari Makino; Keisuke Sakai; Shinichi Masuguchi; Satoshi Fukushima; Masatoshi Jinnin; Yuji Inoue; Hiroshi Koga; Takashi Hashimoto; Hironobu Ihn
Journal:  J Dermatol       Date:  2013-02-11       Impact factor: 4.005

3.  Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.

Authors:  G J Anhalt; S C Kim; J R Stanley; N J Korman; D A Jabs; M Kory; H Izumi; H Ratrie; D Mutasim; L Ariss-Abdo
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

Review 4.  Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.

Authors:  M Heizmann; P Itin; M Wernli; L Borradori; M J Bargetzi
Journal:  Am J Hematol       Date:  2001-02       Impact factor: 10.047

5.  Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus.

Authors:  P Joly; C Richard; D Gilbert; P Courville; O Chosidow; J C Roujeau; M Beylot-Barry; M D'incan; P Martel; P Lauret; F Tron
Journal:  J Am Acad Dermatol       Date:  2000-10       Impact factor: 11.527

6.  Rituximab Monotherapy and Rituximab-Containing Chemotherapy Were Effective for Paraneoplastic Pemphigus Accompanying Follicular Lymphoma, but not for Subsequent Bronchiolitis Obliterans.

Authors:  Taichi Hirano; Yusuke Higuchi; Hiromichi Yuki; Shinya Hirata; Kisato Nosaka; Norito Ishii; Takashi Hashimoto; Hiroaki Mitsuya; Yutaka Okuno
Journal:  J Clin Exp Hematop       Date:  2015

Review 7.  Rituximab in treatment-resistant autoimmune blistering skin disorders.

Authors:  Enno Schmidt; Eva-Bettina Bröcker; Matthias Goebeler
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

Review 8.  Paraneoplastic pemphigus.

Authors:  Xuejun Zhu; Bingxin Zhang
Journal:  J Dermatol       Date:  2007-08       Impact factor: 4.005

9.  Paraneoplastic pemphigus mimicking toxic epidermal necrolysis: An underdiagnosed entity?

Authors:  R Matthew McLarney; Rodrigo H Valdes-Rodriguez; Gabriel Isaza-Gonzalez; Jason H Miller; Sylvia Hsu; Kiran Motaparthi
Journal:  JAAD Case Rep       Date:  2017-12-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.